Horizon Discovery Takes Exclusive License for Transposon-based Gene Editing Technology Platform

Product News   Jul 05, 2017

 
Horizon Discovery Takes Exclusive License for Transposon-based Gene Editing Technology Platform
 
 
FURTHER INFORMATION
 
 
 

Related Product News

QIAGEN Announces European Launch of QIAstat-Dx

Product News

Posters by early adopters demonstrate accurate, fast, cost-effective and flexible diagnosis of syndromic infections and other diseases in unique and versatile Sample to Insight workflows.

READ MORE

Cobra Biologics Receives the Queen’s Award for Enterprise in International Trade

Product News

The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products.

READ MORE

Safe Evaporation Under Inert Atmosphere

Product News

Genevac announce HT Series 3 evaporators with Inert Gas Purge (IGP) option enable safe operation even when removing highly explosive solvents such as diethyl ether.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE